Article content

Actor Ben Stiller’s disclosure this week that he had prostate cancer, and his public plea for early screening — despite the medical evidence against it — has some health experts decrying it as the “Jolie effect.”

In an interview on Howard Stern’s Sirius XM radio show and an essay later posted on Medium.com, the Zoolander actor said he owes his life to the prostate specific antigen (PSA) test — the same test doctors are being strongly advised not to use with asymptomatic men, particularly younger men like Stiller.

We apologize, but this video has failed to load.

tap here to see other videos from our team. Try refreshing your browser, or Ben Stiller’s plea for controversial early prostate cancer screening has experts fearing ‘Jolie effect’ Back to video

The PSA test measures a protein produced by the prostate gland. The higher the man’s blood PSA levels, the more likely he is thought to have cancer.

Once hailed as a landmark in early cancer detection, PSA screening was dealt a serious blow in 2012, when the U.S. Preventive Services Task Force — soon followed by a similar Canadian panel — argued the test saves few, if any, extra lives yet leads men to be treated for cancers that never would have killed had they not been unearthed.